Login / Signup

SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020.

Satoshi KutsunaTadaki SuzukiKayoko HayakawaShinya TsuzukiYusuke AsaiTetsuya SuzukiSatoshi IdeKeiji NakamuraYuki MoriyamaNoriko KinoshitaNaoto HosokawaRyosuke OsawaRyosuke YamamuroYutaro AkiyamaYusuke MiyazatoHidetoshi NomotoTakato NakamotoMasayuki OtaSho SaitoMasahiro IshikaneShinichiro MoriokaKei YamamotoMugen UjiieMari TeradaFukumi Nakamura-UchiyamaToshinori SaharaMasahiro SanoAkifumi ImamuraNoritaka SekiyaKazuaki FukushimaAkihiko KawanaYuji FujikuraTomoya SanoRyohei SuematsuNaoya SakamotoKaoru NagataTomoyuki KatoHarutaka KatanoTakaji WakitaHaruhito SugiyamaNorihiro KokudoNorio Ohmagari
Published in: Open forum infectious diseases (2020)
Our results will be important insights on screening returnees from locked-down cities, as well as providing important data on the proportion of asymptomatic individuals infected with SARS-CoV-2. A 13-day observation period and a second round of PCR may be effective to screen patients, including asymptomatic infections.
Keyphrases
  • sars cov
  • end stage renal disease
  • respiratory syndrome coronavirus
  • ejection fraction
  • newly diagnosed
  • coronavirus disease
  • prognostic factors
  • high throughput
  • patient reported outcomes
  • deep learning
  • data analysis